Accelerate Drug Discovery and Manage Supply Chains with SWIRL

Pharmaceutical companies accelerate drug discovery by using SWIRL to integrate data from clinical trials, laboratory experiments, research papers, and patient records.

SWIRL harnesses AI to identify promising lines of research, spot gaps, and quickly generate summaries.

Pharmaceutical companies use SWIRL to optimize supply chains for critical medicines by getting integrated, AI-driven insights from multiple systems – inventory, logistics, production, and more.

SWIRL enables pharmaceutical companies to improve regulatory compliance by simplifying the process of identifying critical updates, summarizing rule changes, and ensuring that compliance teams are up to date.